Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum - PubMed (original) (raw)
C Dumanchin, D Hannequin, B Dubois, S Belliard, M Puel, C Thomas-Anterion, A Michon, C Martin, F Charbonnier, G Raux, A Camuzat, C Penet, V Mesnage, M Martinez, F Clerget-Darpoux, A Brice, T Frebourg
Affiliations
- PMID: 10441572
- PMCID: PMC1377972
- DOI: 10.1086/302553
Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum
D Campion et al. Am J Hum Genet. 1999 Sep.
Abstract
To determine the prevalence of early-onset Alzheimer disease (EOAD) and of autosomal dominant forms of EOAD (ADEOAD), we performed a population-based study in the city of Rouen (426,710 residents). EOAD was defined as onset of disease at age <61 years, and ADEOAD was defined as the occurrence of at least three EOAD cases in three generations. Using these stringent criteria, we calculated that the EOAD and ADEOAD prevalences per 100,000 persons at risk were 41.2 and 5.3, respectively. We then performed a mutational analysis of the genes for amyloid precursor protein (APP), presenilin 1 (PSEN1), and presenilin 2 (PSEN2) in 34 families with ADEOAD ascertained in France. In 19 (56%) of these families, we identified 16 distinct PSEN1 missense mutations, including 4 (Thr147Ile, Trp165Cys, Leu173Trp, and Ser390Ile) not reported elsewhere. APP mutations, including a novel mutation located at codon 715, were identified in 5 (15%) of the families. In the 10 remaining ADEOAD families and in 9 additional autosomal dominant Alzheimer disease families that did not fulfill the strict criteria for ADEOAD, no PSEN1, PSEN2, or APP mutation was identified. These results show that (1) PSEN1 and APP mutations account for 71% of ADEOAD families and (2) nonpenetrance at age <61 years is probably infrequent for PSEN1 or APP mutations.
Similar articles
- APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases.
Lanoiselée HM, Nicolas G, Wallon D, Rovelet-Lecrux A, Lacour M, Rousseau S, Richard AC, Pasquier F, Rollin-Sillaire A, Martinaud O, Quillard-Muraine M, de la Sayette V, Boutoleau-Bretonniere C, Etcharry-Bouyx F, Chauviré V, Sarazin M, le Ber I, Epelbaum S, Jonveaux T, Rouaud O, Ceccaldi M, Félician O, Godefroy O, Formaglio M, Croisile B, Auriacombe S, Chamard L, Vincent JL, Sauvée M, Marelli-Tosi C, Gabelle A, Ozsancak C, Pariente J, Paquet C, Hannequin D, Campion D; collaborators of the CNR-MAJ project. Lanoiselée HM, et al. PLoS Med. 2017 Mar 28;14(3):e1002270. doi: 10.1371/journal.pmed.1002270. eCollection 2017 Mar. PLoS Med. 2017. PMID: 28350801 Free PMC article. - Molecular diagnosis of autosomal dominant early onset Alzheimer's disease: an update.
Raux G, Guyant-Maréchal L, Martin C, Bou J, Penet C, Brice A, Hannequin D, Frebourg T, Campion D. Raux G, et al. J Med Genet. 2005 Oct;42(10):793-5. doi: 10.1136/jmg.2005.033456. Epub 2005 Jul 20. J Med Genet. 2005. PMID: 16033913 Free PMC article. - APP, PSEN1, and PSEN2 Mutations in Asian Patients with Early-Onset Alzheimer Disease.
Giau VV, Bagyinszky E, Youn YC, An SSA, Kim S. Giau VV, et al. Int J Mol Sci. 2019 Sep 25;20(19):4757. doi: 10.3390/ijms20194757. Int J Mol Sci. 2019. PMID: 31557888 Free PMC article. - [Genetic counseling and testing for families with Alzheimer's disease].
Kowalska A. Kowalska A. Neurol Neurochir Pol. 2004 Nov-Dec;38(6):495-501. Neurol Neurochir Pol. 2004. PMID: 15654674 Review. Polish. - Three-year follow-up of a patient with early-onset Alzheimer's disease with presenilin-2 N141I mutation - case report and review of the literature.
Nikisch G, Hertel A, Kiessling B, Wagner T, Krasz D, Hofmann E, Wiedemann G. Nikisch G, et al. Eur J Med Res. 2008 Dec 3;13(12):579-84. Eur J Med Res. 2008. PMID: 19073399 Review.
Cited by
- Energetic portrait of the amyloid beta nucleation transition state.
Arutyunyan A, Seuma M, Faure AJ, Bolognesi B, Lehner B. Arutyunyan A, et al. bioRxiv [Preprint]. 2024 Jul 24:2024.07.24.604935. doi: 10.1101/2024.07.24.604935. bioRxiv. 2024. PMID: 39091732 Free PMC article. Preprint. - Apo and Aβ46-bound γ-secretase structures provide insights into amyloid-β processing by the APH-1B isoform.
Odorčić I, Hamed MB, Lismont S, Chávez-Gutiérrez L, Efremov RG. Odorčić I, et al. Nat Commun. 2024 May 27;15(1):4479. doi: 10.1038/s41467-024-48776-2. Nat Commun. 2024. PMID: 38802343 Free PMC article. - Molecular neuroimaging in dominantly inherited versus sporadic early-onset Alzheimer's disease.
Iaccarino L, Llibre-Guerra JJ, McDade E, Edwards L, Gordon B, Benzinger T, Hassenstab J, Kramer JH, Li Y, Miller BL, Miller Z, Morris JC, Mundada N, Perrin RJ, Rosen HJ, Soleimani-Meigooni D, Strom A, Tsoy E, Wang G, Xiong C, Allegri R, Chrem P, Vazquez S, Berman SB, Chhatwal J, Masters CL, Farlow MR, Jucker M, Levin J, Salloway S, Fox NC, Day GS, Gorno-Tempini ML, Boxer AL, La Joie R, Bateman R, Rabinovici GD. Iaccarino L, et al. Brain Commun. 2024 May 3;6(3):fcae159. doi: 10.1093/braincomms/fcae159. eCollection 2024. Brain Commun. 2024. PMID: 38784820 Free PMC article. - Early molecular events of autosomal-dominant Alzheimer's disease in marmosets with PSEN1 mutations.
Homanics GE, Park JE, Bailey L, Schaeffer DJ, Schaeffer L, He J, Li S, Zhang T, Haber A, Spruce C, Greenwood A, Murai T, Schultz L, Mongeau L, Ha SK, Oluoch J, Stein B, Choi SH, Huhe H, Thathiah A, Strick PL, Carter GW, Silva AC, Sukoff Rizzo SJ. Homanics GE, et al. Alzheimers Dement. 2024 May;20(5):3455-3471. doi: 10.1002/alz.13806. Epub 2024 Apr 4. Alzheimers Dement. 2024. PMID: 38574388 Free PMC article. - APOEε4 Carriers Exhibit Objective Cognitive Deficits: A Cross-Sectional Study in a Single Center Trial.
Zeng Y, Du W, Zhang M, Walker A, Han Y, Ding Y. Zeng Y, et al. Brain Sci. 2024 Mar 15;14(3):281. doi: 10.3390/brainsci14030281. Brain Sci. 2024. PMID: 38539669 Free PMC article.
References
- Hum Mol Genet. 1995 Dec;4(12):2373-7 - PubMed
- Neurosci Lett. 1998 Jan 16;240(3):174-6 - PubMed
- Neuroreport. 1995 Dec 29;7(1):297-301 - PubMed
- Ann Neurol. 1996 Aug;40(2):265-6 - PubMed
- Hum Mol Genet. 1996 Jul;5(7):985-8 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases